FTC sues major pharmacy profit supervisors in excess of insulin costs The agency introduced motion from Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the list price of life-preserving insulin medicine. Hear the report 10 min This audio is car-created. Be sure to https://buschpeachcalories50505.blogginaway.com/31227559/the-smart-trick-of-healthcare-news-that-nobody-is-discussing